According to a ranking by Statista and Newsweek, the best hospital in Denmark is the Rigshospitalet - København in Copenhagen. Moreover, the Rigshospitalet - København was also ranked as the **** best hospital in the world, among over ****** hospitals in ** countries. Aarhus Universitetshospital in Aarhus and Odense Universitetshospital in Odense were ranked as second and third best respectively in the Denmark, while they were **** and **** best respectively in the World.

According to a ranking by Statista and Newsweek, the best hospital in Sweden is the Karolinska Universitetssjukhuset in Stockholm. Moreover, Karolinska Universitetssjukhuset was also ranked as the seventh-best hospital in the world, among over ****** hospitals in ** countries. Sahlgrenska Universitetssjukhuset in Göteborg and Akademiska Sjukhuset in Uppsala were ranked as second and third best respectively in the Sweden, while they were **** and **** best respectively in the World.

According to a ranking by Statista and Newsweek, the best hospital in Finland is Helsinki University Hospital in Helsinki. Moreover, Helsinki University Hospital was also ranked as the **** best hospital in the world, among over ****** hospitals in ** countries. Tampere University Hospital in Tampere and Turku University Hospital in Turku were ranked as second and third best respectively in the Finland, while they were ***** and ***** best respectively in the World.

According to a ranking by Statista and Newsweek, the best hospital in the United States is the *********** in Rochester, Minnesota. Moreover, the *********** was also ranked as the best hospital in the world, among over 50,000 hospitals in 30 countries. **************** in Ohio and the ************* Hospital in Maryland were ranked as second and third best respectively in the U.S., while they were second and forth best respectively in the World.

The dataset contains risk-adjusted mortality rates, quality ratings, and number of deaths and cases for 6 medical conditions treated (Acute Stroke, Acute Myocardial Infarction, Heart Failure, Gastrointestinal Hemorrhage, Hip Fracture and Pneumonia) and 3 procedures performed (Carotid Endarterectomy, Pancreatic Resection, and Percutaneous Coronary Intervention) in California hospitals. The 2023 IMIs were generated using AHRQ Version 2024, while previous years' IMIs were generated with older versions of AHRQ software (2022 IMIs by Version 2023, 2021 IMIs by Version 2022, 2020 IMIs by Version 2021, 2019 IMIs by Version 2020, 2016-2018 IMIs by Version 2019, 2014 and 2015 IMIs by Version 5.0, and 2012 and 2013 IMIs by Version 4.5). The differences in the statistical method employed and inclusion and exclusion criteria using different versions can lead to different results. Users should not compare trends of mortality rates over time. However, many hospitals showed consistent performance over years; “better” performing hospitals may perform better and “worse” performing hospitals may perform worse consistently across years. This dataset does not include conditions treated or procedures performed in outpatient settings. Please refer to statewide table for California overall rates: https://data.chhs.ca.gov/dataset/california-hospital-inpatient-mortality-rates-and-quality-ratings/resource/af88090e-b6f5-4f65-a7ea-d613e6569d96

With over 6,500 medical centers, Brazil was the Latin American country with the highest number of hospitals in 2024, among the countries depicted. Mexico ranked second, with 3,587 hospitals. In 2022, Hospital Israelita Albert Einstein was the leading hospital by quality in the South American country. Healthcare spending With an estimated 11 percent of its gross domestic product (GDP) being spent on health, Cuba was the nation with the highest health expenditure share in Latin America and the Caribbean in 2020. Ranking second in this ranking along with Argentina, Brazil’s government spent more than 46 percent of its annual health expenditure on hospital and outpatient care. Meanwhile, in Chile, government spending on healthcare was, on average, about 1,679 U.S. dollars per person in 2021, which was more than the combined health expenditure from government and out-of-pocket spending in Mexico. Leading medical technology Including products such as diagnostic imaging, implants, and vaccines, nanomedicine has by far been Latin America’s most valuable medical technology, generating an estimated 19.36 billion U.S. dollars in 2022. Furthermore, the revenue of nanomedicine in the region is expected to reach 37.45 billion U.S. dollars by 2027, representing an increase of more than 94 percent over a span of five years.More information by Global Health Intelligence on hospital infrastructure in various Latin American countries can be found here.

According to a ranking of the best hospitals in the U.S., the best hospital for adult cancer is the University of *******************************, which had a score of *** out of 100, as of 2025. This statistic shows the top 10 hospitals for adult cancer in the United States based on the score given by U.S. News and World Report's annual hospital ranking.

Annual Excel pivot tables display the top 25 MS-DRGs (Medicare Severity-Diagnosis Related Groups) per hospital. The ranking can be sorted by the number of discharges, average charge per stay, or average length of stay.

According to a ranking by Statista and Newsweek, the best hospital in Norway is Oslo Universitetssykehus in Oslo. Moreover, Oslo Universitetssykehus was also ranked as the **** best hospital in the world, among over ****** hospitals in ** countries. St. Olavs Hospital in Trondheim and Haukeland Universitetssykehus in Bergen were ranked as second and third best respectively in the Norway, while they were ***** and ***** best respectively in the World.

With *** operating rooms, **************************** in Ohio was the hospital with the highest number of operating rooms in the United States in 2024. That year, there were a total of ****** operating rooms in U.S. hospitals.

Change-In-Other-Working-Capital Time Series for Chularat Hospital Public Company Limited. Chularat Hospital Public Company Limited operates clinics and hospitals in Thailand. The company operates cancer treatment, aesthetic, social security, occupational health examination, and Thai traditional medicine centers, as well as drug auction systems. It also sells medicine and medical supplies. Chularat Hospital Public Company Limited was founded in 1986 is headquartered in Samut Prakan, Thailand.

Other-Appropriated-Reserves Time Series for Ramkhamhaeng Hospital Public Company Limited. Ramkhamhaeng Hospital Public Company Limited, together with its subsidiaries, operates as a private hospital in Thailand. The company operates in Hospital and Other segments. It also engages in the sale of medical equipment and instruments, as well as offers property development and training services. The company was founded in 1976 and is based in Bangkok, Thailand.

The dataset provides performance ratings for two outcome measures for transcatheter aortic valve replacement (TAVR) procedures: in-hospital/30-day mortality and in-hospital/30-day stroke. It includes the number of cases, adverse events, risk-adjusted rates, and performance ratings for hospitals compared to the overall statewide rates. This dataset also contains the location of hospitals that perform TAVR procedures in California.

In 2024, Bumrungrad International Hospital ranked first among the leading hospitals in Thailand with a score of ** percent. In the same year, it was the only hospital from Thailand that placed 130th among the *** world's best hospitals on the Global Hospital Rating by Newsweek and Statista. Thailand is one of the most popular medical tourism hubs in Southeast Asia.

Change-To-Liabilities Time Series for Aier Eye Hospital Group. Aier Eye Hospital Group Co., Ltd. operates eye care hospitals and institutions. The company offers medical services in the areas of fundus diseases, optometry, refractive correction, glaucoma, corneal diseases, and cataract. It also provides training course for cataract prevention and treatment. The company operates ophthalmic hospitals in mainland China, Europe, the United States, Hong Kong, and Southeast Asia. The company was founded in 2007 and is headquartered in Changsha, China.

Smart Mattress Overlay (Hospital) Market Outlook

According to our latest research, the global Smart Mattress Overlay (Hospital) market size reached USD 1.21 billion in 2024, and the industry is projected to grow at a robust CAGR of 7.8% from 2025 to 2033. By the end of the forecast period, the market is expected to attain a value of USD 2.39 billion in 2033. This remarkable growth trajectory is primarily driven by the increasing focus on patient comfort, the rising prevalence of pressure ulcers, and the rapid integration of advanced sensor-based technologies in hospital settings. As per the latest research, hospitals and healthcare providers are increasingly adopting smart mattress overlays to enhance patient outcomes and reduce complications associated with prolonged immobility.

The growth of the Smart Mattress Overlay (Hospital) market is significantly influenced by the escalating incidence of pressure ulcers and hospital-acquired conditions among immobile and critically ill patients. With the global population aging and the number of patients requiring long-term care rising, healthcare facilities are under mounting pressure to adopt advanced solutions that can effectively mitigate the risks associated with extended bed rest. Smart mattress overlays, particularly those equipped with pressure redistribution and alternating pressure technologies, have emerged as essential tools in this context. These devices not only improve patient comfort but also play a pivotal role in preventing costly and potentially life-threatening complications, thereby driving their widespread adoption across hospitals and long-term care facilities.

Another key factor propelling market expansion is the rapid technological advancement in sensor-based and connected healthcare devices. The integration of Internet of Things (IoT) and artificial intelligence (AI) within smart mattress overlays has enabled real-time monitoring of patient movement, pressure points, and sleep patterns. This data-driven approach allows healthcare providers to make informed decisions, optimize care plans, and intervene proactively to prevent the onset of pressure ulcers. The development of wireless connectivity and remote monitoring features has further enhanced the utility of these overlays, making them indispensable in both acute and chronic care environments. Additionally, the growing emphasis on improving patient satisfaction scores and hospital ratings is encouraging healthcare administrators to invest in these advanced solutions.

The Smart Mattress Overlay (Hospital) market is also benefitting from favorable reimbursement policies and government initiatives aimed at enhancing patient safety and reducing healthcare costs. Various health authorities across North America and Europe have introduced guidelines and financial incentives to promote the adoption of pressure-relieving devices in hospitals. These regulatory frameworks, coupled with increasing awareness among healthcare professionals about the benefits of smart overlays, are accelerating market penetration. Furthermore, collaborations between medical device manufacturers and healthcare providers are fostering the development of innovative products tailored to specific patient populations, thereby expanding the market's reach and appeal.

From a regional perspective, North America continues to dominate the Smart Mattress Overlay (Hospital) market, owing to its advanced healthcare infrastructure, high healthcare expenditure, and early adoption of cutting-edge medical technologies. Europe follows closely, supported by stringent regulations on patient safety and a well-established network of long-term care facilities. The Asia Pacific region, on the other hand, is poised for the fastest growth during the forecast period, driven by increasing healthcare investments, a rapidly aging population, and rising awareness about pressure ulcer prevention. Latin America and the Middle East & Africa are also witnessing gradual adoption, though their market shares remain comparatively smaller due to limited access to advanced healthcare technologies and budget constraints.

Other-Appropriated-Reserves Time Series for Vibhavadi Medical Center Public Company Limited. Vibhavadi Medical Center Public Company Limited operates a hospital under the Vibhavadi Hospital name in Thailand. It operates through two segments, Hospital and Others. The company provides medical services; and rental services and space rental. It engages in the beauty business; and operation of anti-aging center and specialized disease clinics. The company was founded in 1986 and is based in Bangkok, Thailand.

Free-Cash-Flow-To-Equity Time Series for Ramkhamhaeng Hospital Public Company Limited. Ramkhamhaeng Hospital Public Company Limited, together with its subsidiaries, operates as a private hospital in Thailand. The company operates in Hospital and Other segments. It also engages in the sale of medical equipment and instruments, as well as offers property development and training services. The company was founded in 1976 and is based in Bangkok, Thailand.

Introduction

The Global Smart Ward Market is poised for significant growth, projected to expand from US$ 3.1 billion in 2023 to an estimated US$ 10.7 billion by 2033, at a compound annual growth rate (CAGR) of 13.2%. North America is at the forefront, holding a dominant 39.8% market share, with US$ 1.2 billion in revenue as of 2023. The region's leadership in this market is underscored by the presence of 87 U.S. and 15 Canadian hospitals ranked among the top 300 smart hospitals globally, according to a Newsweek report. This leadership is primarily fueled by extensive investments in digital health technologies and an increasing focus on enhancing patient care efficiency.

In terms of technological innovation, the Smart Ward sector is driven by the integration of advanced digital infrastructures like the Internet of Things (IoT) and Artificial Intelligence (AI). These technologies are crucial in optimizing hospital operations, improving patient monitoring, and enhancing overall healthcare delivery. The trend towards digitalization is not only improving workflow efficiencies but also supports predictive maintenance of medical equipment, which is vital in managing the rising aging population and the growing prevalence of chronic diseases.

The growth of smart wards also relies on robust policy frameworks that address data privacy, cybersecurity, and ethical technology use. Ensuring that these technological advancements are governed by comprehensive policies will facilitate their safe integration into healthcare settings, thus protecting both patients and healthcare providers. Furthermore, continuous training and capacity building for healthcare professionals are emphasized to equip them with the necessary skills to adapt to these new technologies and protocols effectively.

Public-Private Partnerships (PPPs) play a pivotal role in accelerating the adoption of smart healthcare solutions. By combining resources, expertise, and funding, these partnerships enhance the scalability of smart wards across various regions. Additionally, smart wards are integral to broader smart city initiatives that prioritize sustainable and inclusive urban development. Ensuring accessibility of smart healthcare solutions across different population segments enhances public health outcomes and supports sustainable development.

Looking ahead, the Asia Pacific region is expected to witness the highest growth rate during the forecast period, driven by increasing healthcare investments and rapid adoption of AI and IoT technologies in countries like India, China, and Japan. The Indian Council of Medical Research (ICMR) has recently published ethical guidelines for AI in healthcare, which is anticipated to boost the integration of AI technologies in healthcare facilities, promoting enhanced patient care and operational efficiency in the region. This surge in technological adoption underscores the dynamic expansion of the Smart Ward Market in Asia Pacific, setting the stage for a transformative impact on the global healthcare landscape.

Cash-Flows-Other-Operating Time Series for Bangkok Chain Hospital Public Company Limited. Bangkok Chain Hospital Public Company Limited, together with its subsidiaries, operates private hospitals in Bangkok vicinity, Chiang Rai, Saraburi, Nonthaburi, Pathumthani, Ayudhaya, Chachoengsao, Prachinburi, Sa Kaeo Province, and Lao People's Democratic Republic. It offers diagnosis, treatment, prevention, rehabilitation services for heart disease; open heart surgery to provide heart care and clinical treatment by cardiologists; and medical supports. The company also operates diagnostic imaging centers; eye centers that provide eye examination, treatment, and surgery services; cancer centers that offer services ranging from screening, diagnosis, and chemotherapy; fertility centers for infertility treatment, as well as diabetic wound treatment centers. In addition, the company sells health-related drinks; provides medical analysis and research services; and develops package computer programs. The company was founded in 1984 and is headquartered in Nonthaburi, Thailand.